SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-141750
Filing Date
2021-11-19
Accepted
2021-11-19 13:33:02
Documents
1
Period of Report
2021-11-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2133436-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2133436-2_4seq1.xml 4 4542
  Complete submission text file 0001104659-21-141750.txt   5926
Mailing Address C/O CASCADIAN THERAPEUTICS, INC. 3101 WESTERN AVE., SUITE 600 SEATTLE WA 98121
Business Address
Myers Scott Dunseth (Reporting) CIK: 0001356256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36596 | Film No.: 211427708

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Issuer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations